샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777856

생물학적 이미징 시약 시장

Biological Imaging Reagents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 340 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생물학적 이미징 시약 시장은 2030년까지 180억 달러에 이를 전망

2024년에 126억 달러로 추정되는 생물학적 이미징 시약 세계 시장은 2024-2030년간 CAGR 6.2%로 성장하여 2030년에는 180억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 조영 시약은 CAGR 7.1%를 나타내고, 분석 기간 종료까지 105억 달러에 이를 것으로 예측됩니다. 광학 시약 부문의 성장률은 분석 기간에 CAGR 5.6%로 추정됩니다.

미국 시장은 34억 달러로 추정, 중국은 CAGR 9.9%로 성장 예측

미국의 생물학적 이미징 시약 시장은 2024년에 34억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR 9.9%로 성장하여 2030년까지 37억 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.0%와 6.1%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.1%를 나타낼 전망입니다.

세계의 생물학적 이미징 시약 시장 - 주요 동향과 촉진요인 정리

생물학적 이미징 시약이 현대의 진단 및 조사에 필수적인 이유는 무엇인가?

생물학적 이미징 시약은 의료 이미징, 생명과학 연구, 의약품 개발의 발전에 필수적입니다. 형광증백제, 조영제, 방사성 추적자를 포함한 이러한 시약은 분자 및 세포 이미징에 사용되는 시각화 기술을 향상시키는 데 중요한 역할을 합니다. 고해상도 이미징과 생물학적 과정을 실시간으로 추적할 수 있는 이러한 능력은 다양한 의료 응용 분야에서 진단 및 치료 모니터링에 변화를 가져오고 있습니다. 암, 신경질환 등 만성질환 증가로 정밀 영상진단 솔루션에 대한 수요가 증가하고 있으며, 생물학적 이미징 시약은 질병의 조기발견과 치료계획에 필수적인 요소로 자리 잡고 있습니다. MRI, PET, CT, 형광 현미경 등 이미징 기법이 발전함에 따라 특이성과 생체적합성을 향상시킨 첨단 시약의 필요성이 증가하고 있습니다. 또한, 개인 맞춤형 의료로의 전환은 표적 진단 및 환자별 치료 접근법을 촉진하는 분자 이미징 시약에 대한 수요를 촉진하고 있습니다.

기술 발전은 이미징 시약의 효율성을 어떻게 향상시키고 있는가?

나노기술, 인공지능, 생물공학의 통합은 생물학적 이미징 시약의 효율성과 특이성을 크게 향상시켰습니다. 나노 입자 기반 조영제의 혁신은 더 깊은 조직 침투와 촬영 시간 연장을 가능하게 하고, 내부 구조를 더 세밀하게 시각화할 수 있게 해줍니다. 또한 pH, 효소 활성 등 환경 변화에 반응하는 스마트 이미징 시약은 질병 진단의 정확도를 높이고 있습니다. 인공지능은 의료 스캔에서 이미지 재구성, 노이즈 제거, 패턴 인식을 개선하여 이미징 시약의 적용을 최적화하는 데 중요한 역할을 하고 있습니다. AI 지원 이미징 기술은 방대한 데이터 세트를 높은 정확도로 분석하여 이미징 시약의 진단 능력을 향상시킬 수 있습니다. 또한, 진단 기능과 치료 기능을 겸비한 다기능 이미징 시약(테라노스틱스)의 개발로 암 치료의 새로운 가능성이 열리고 있으며, 표적 치료를 하면서 치료 효과를 실시간으로 모니터링할 수 있게 되었습니다.

어떤 시장 동향이 생물학적 이미징 시약의 채택을 촉진하고 있는가?

생물학적 이미징 시약 시장을 형성하는 주요 트렌드 중 하나는 비침습적 진단 기술에 대한 관심이 높아지고 있다는 점입니다. 의료 서비스 제공업체와 연구자들은 환자의 불편함을 줄이면서 높은 정확도의 결과를 제공하는 이미징 솔루션을 우선시하고 있습니다. 이러한 추세는 외과적 개입 없이 분자 수준에서 가시성을 강화하는 새로운 이미징 약물에 대한 투자를 촉진하고 있습니다. 또 다른 큰 시장 트렌드는 제약기업과 영상기술 개발 기업과의 협력관계 확대입니다. 새로운 이미징 시약을 이용한 전임상 및 임상시험의 확대로 신약개발 및 치료 평가가 가속화되고 있습니다. 또한, 신경과학, 종양학, 심혈관 연구 분야에서 실시간 생체 내 이미징 솔루션에 대한 수요가 증가하면서 시장 확대에 더욱 박차를 가하고 있습니다. 이미징 양식의 개선에 대한 요구가 계속 증가함에 따라 각 제조업체는 보다 안전하고 효율적이며 타겟팅된 개발에 집중하고 있습니다.

생물학적 이미징 시약 시장의 주요 성장 촉진요인은 무엇인가?

생물학적 이미징 시약 시장의 성장은 이미징 기술의 발전, 만성 질환의 유병률 증가, 임상 진단에서 분자 이미징의 채택 증가 등 여러 가지 요인으로 인해 발생합니다. 하이브리드 이미징 시스템(PET-MRI, SPECT-CT)과 같은 이미징 플랫폼의 지속적인 진화는 대비와 이미징 해상도를 높이는 특수 시약에 대한 수요를 증가시키고 있습니다. 생명공학 및 제약 연구의 확대는 신약 개발, 바이오마커 식별, 질병 병리 연구에 필수적인 도구이기 때문에 주요 성장 촉진요인으로 작용하고 있습니다. 또한, 정밀의료와 개인 맞춤형 헬스케어에 대한 투자가 증가하면서 진단 정확도와 치료 효과를 향상시키는 표적 이미징 약물의 필요성이 높아지고 있습니다. 질병의 조기 발견, 최소침습적 진단, AI 지원 영상 솔루션에 대한 관심이 높아지면서 생물학적 이미징 시약 시장은 견조한 성장세를 보이며 의료 영상 진단 및 생물 의학 연구의 미래를 형성하고 있습니다.

부문

제품 유형(조영, 광학, 핵), 이미징 모달리티(광학, MRI, 초음파, X선 및 CT, 핵), 용도(임상 진단, Drug Discovery 개발, 연구개발, 기타), 최종 용도(영상 진단센터, 병원, 연구 및 학술기관, 기타)

조사 대상 기업 예

  • ABX advanced biochemical compounds GmbH
  • Advanced Proteome Therapeutics Corporation
  • Bayer AG
  • Beckman Coulter Inc.
  • BIOPRO Baden-Wurttemberg GmbH
  • Cardinal Health
  • Cell Signaling Technology
  • Danaher Corporation
  • FujiFilm VisualSonics, Inc.
  • General Electric Company
  • Guerbet GmbH
  • Jubilant Pharmova Ltd.
  • Koninklijke Philips NV
  • Nikon Corporation
  • Novartis AG
  • Olympus Corporation
  • PerkinElmer
  • Philips Healthcare
  • Promega Corporation
  • Sartorius AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.04

Global Biological Imaging Reagents Market to Reach US$18.0 Billion by 2030

The global market for Biological Imaging Reagents estimated at US$12.6 Billion in the year 2024, is expected to reach US$18.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Contrast Reagents, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$10.5 Billion by the end of the analysis period. Growth in the Optical Reagents segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 9.9% CAGR

The Biological Imaging Reagents market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Biological Imaging Reagents Market - Key Trends & Drivers Summarized

Why Are Biological Imaging Reagents Essential in Modern Diagnostics and Research?

Biological imaging reagents are integral to the advancements in medical imaging, life sciences research, and drug development. These reagents, including fluorescent dyes, contrast agents, and radiotracers, play a crucial role in enhancing visualization techniques used in molecular and cellular imaging. Their ability to provide high-resolution imaging and real-time tracking of biological processes is transforming diagnostics and therapeutic monitoring across a range of medical applications. The increasing prevalence of chronic diseases, such as cancer and neurological disorders, has heightened the demand for precise imaging solutions, making biological imaging reagents indispensable in early disease detection and treatment planning. As imaging modalities such as MRI, PET, CT, and fluorescence microscopy evolve, the need for advanced reagents that offer improved specificity and biocompatibility is growing. Furthermore, the shift toward personalized medicine is driving demand for molecular imaging reagents that facilitate targeted diagnostics and patient-specific treatment approaches.

How Are Technological Advancements Enhancing the Efficiency of Imaging Reagents?

The integration of nanotechnology, artificial intelligence, and bioengineering is significantly improving the efficiency and specificity of biological imaging reagents. Innovations in nanoparticle-based contrast agents are enabling deeper tissue penetration and prolonged imaging durations, allowing for more detailed visualization of internal structures. Additionally, smart imaging reagents that respond to environmental changes, such as pH or enzyme activity, are enhancing the precision of disease diagnostics. Artificial intelligence is playing a crucial role in optimizing imaging reagent application by improving image reconstruction, noise reduction, and pattern recognition in medical scans. AI-assisted imaging technologies can analyze vast datasets with high accuracy, increasing the diagnostic capabilities of imaging reagents. Furthermore, the development of multifunctional imaging agents, which combine diagnostic and therapeutic functionalities (theranostics), is opening new opportunities in cancer treatment, enabling real-time monitoring of treatment efficacy while delivering targeted therapy.

What Market Trends Are Driving the Adoption of Biological Imaging Reagents?

One of the key trends shaping the biological imaging reagents market is the increasing focus on non-invasive diagnostic techniques. Healthcare providers and researchers are prioritizing imaging solutions that reduce patient discomfort while delivering high-precision results. This trend is driving investments in novel imaging agents that enhance visualization at the molecular level without requiring surgical intervention. Another significant market trend is the growing collaboration between pharmaceutical companies and imaging technology developers. The expansion of preclinical and clinical trials involving novel imaging reagents is accelerating drug discovery and therapeutic assessment. Additionally, the demand for real-time, in vivo imaging solutions is growing in the field of neuroscience, oncology, and cardiovascular research, further propelling market expansion. As the need for improved imaging modalities continues to rise, manufacturers are focusing on developing safer, more efficient, and highly targeted biological imaging reagents.

What Are the Key Growth Drivers for the Biological Imaging Reagents Market?

The growth in the Biological Imaging Reagents market is driven by several factors, including advancements in imaging technologies, increasing prevalence of chronic diseases, and the rising adoption of molecular imaging in clinical diagnostics. The continuous evolution of imaging platforms, such as hybrid imaging systems (PET-MRI, SPECT-CT), is boosting the demand for specialized reagents that enhance contrast and imaging resolution. The expansion of biotechnology and pharmaceutical research is also a major growth driver, as biological imaging reagents are essential tools for drug discovery, biomarker identification, and disease pathology research. Furthermore, the increasing investments in precision medicine and personalized healthcare are driving the need for targeted imaging agents that improve diagnostic accuracy and treatment efficacy. With the growing focus on early disease detection, minimally invasive diagnostics, and AI-assisted imaging solutions, the biological imaging reagents market is poised for robust growth, shaping the future of medical imaging and biomedical research.

SCOPE OF STUDY:

The report analyzes the Biological Imaging Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Contrast Reagents, Optical Reagents, Nuclear Reagents); Imaging Modality (Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality, Nuclear Imaging Modality); Application (Clinical Diagnostics Application, Drug Discovery and Development Application, Research and #innovation Application, Other Applications); End-Use (Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research and Academic Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • ABX advanced biochemical compounds GmbH
  • Advanced Proteome Therapeutics Corporation
  • Bayer AG
  • Beckman Coulter Inc.
  • BIOPRO Baden-Wurttemberg GmbH
  • Cardinal Health
  • Cell Signaling Technology
  • Danaher Corporation
  • FujiFilm VisualSonics, Inc.
  • General Electric Company
  • Guerbet GmbH
  • Jubilant Pharmova Ltd.
  • Koninklijke Philips NV
  • Nikon Corporation
  • Novartis AG
  • Olympus Corporation
  • PerkinElmer
  • Philips Healthcare
  • Promega Corporation
  • Sartorius AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Imaging Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Cancer Propels Demand for Advanced Imaging Reagents
    • Technological Innovations in Molecular Imaging Strengthen Business Case for Targeted Reagents
    • Growth in Personalized Medicine and Precision Diagnostics Expands Addressable Market for Imaging Reagents
    • Increased Research in Cell Biology and Pathology Throws Spotlight on Novel Imaging Biomarkers
    • Integration with AI and Imaging Software Enhances Accuracy and Interpretation of Imaging Reagents
    • Expansion of Preclinical and Translational Research Generates Demand for Specialized Reagent Kits
    • Funding for Biomedical Research Sustains Growth in Academic and Institutional Adoption
    • High Demand for Non-Invasive Diagnostic Tools Spurs Adoption of Biocompatible Imaging Reagents
    • Shift Toward Multimodal Imaging Techniques Generates Demand for Versatile Imaging Reagents
    • Commercialization of Novel Nanoparticle-Based Reagents Expands Application Scope in Oncology
    • Increased Focus on Live-Cell Imaging and Real-Time Monitoring Drives Innovation in Reagent Design
    • Rising Use in Companion Diagnostics Enhances Market Relevance in Targeted Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biological Imaging Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contrast Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Contrast Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Optical Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Optical Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nuclear Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Nuclear Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Research & #innovation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Research & #innovation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Optical Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Optical Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for MRI Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for MRI Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Ultrasound Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Ultrasound Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for X-ray and CT Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for X-ray and CT Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Nuclear Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • JAPAN
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CHINA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • EUROPE
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • FRANCE
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • GERMANY
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 112: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Spain 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 114: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Spain 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • RUSSIA
    • TABLE 118: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Russia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 120: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Russia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Russia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • AUSTRALIA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 144: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Australia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Australia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 148: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Australia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 150: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Australia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • INDIA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 152: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: India 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 154: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: India 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 156: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 157: India 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 160: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 161: South Korea 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 162: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 163: South Korea 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: South Korea 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 166: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 167: South Korea 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 168: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 170: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 172: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 174: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • LATIN AMERICA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 176: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Latin America 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 178: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Latin America 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 180: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Latin America 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Latin America 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 184: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Latin America 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 186: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Argentina 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 188: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Argentina 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 190: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 191: Argentina 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 192: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 193: Argentina 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • BRAZIL
    • TABLE 194: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Brazil 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 196: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Brazil 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 198: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Brazil 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 200: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Brazil 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • MEXICO
    • TABLE 202: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Mexico 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 204: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Mexico 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 206: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Mexico 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 208: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 209: Mexico 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 210: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 211: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 212: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 214: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 215: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 216: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 217: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • MIDDLE EAST
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 218: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 219: Middle East 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 220: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 221: Middle East 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 222: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 223: Middle East 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 224: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Middle East 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 226: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 227: Middle East 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • IRAN
    • TABLE 228: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 229: Iran 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 230: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Iran 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 232: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 233: Iran 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 234: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 235: Iran 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ISRAEL
    • TABLE 236: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Israel 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 238: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 239: Israel 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 240: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 241: Israel 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 242: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Israel 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 244: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 245: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 246: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 247: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 248: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 250: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 251: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 252: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 253: UAE 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 254: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: UAE 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 256: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 257: UAE 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 258: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 259: UAE 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 262: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 263: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 264: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 265: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 266: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • AFRICA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 268: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 269: Africa 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 270: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 271: Africa 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 272: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Africa 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 274: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 275: Africa 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제